Agoracom: Small Cap Investment - Zenith Epigenetics - Re: More Exempt Distribution Investments

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

More Exempt Distribution Investments

KOO-KOO2

Jan 05, 2024 02:49PM

Re: More Exempt Distribution Investments

fuzzyjr

Jan 05, 2024 03:22PM

Re: More Exempt Distribution Investments

KOO-KOO2

Jan 05, 2024 03:27PM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: More Exempt Distribution Investments

in response to

Re: More Exempt Distribution Investments

KOO-KOO2

posted on Jan 05, 2024 03:37PM

Thanks koo - was it all done at the same pricing .85can or whatever the number was? One would think as time goes on these things would start to move up significantly.

Re: More Exempt Distribution Investments

KOO-KOO2

Jan 05, 2024 04:43PM

Re: More Exempt Distribution Investments

fuzzyjr

Jan 05, 2024 04:47PM

Re: More Exempt Distribution Investments

KOO-KOO2

Jan 05, 2024 05:24PM

Re: More Exempt Distribution Investments

fuzzyjr

Feb 28, 2024 04:32PM